Scarica l'app Stockscreener
18.59
6.71%
1.08
Precedente Chiudi:
$17.51
Aprire:
$17.46
Volume 24 ore:
759.59K
Relative Volume:
0.53
Capitalizzazione di mercato:
$1.70B
Reddito:
$12.59M
Utile/perdita netta:
$-212.39M
Rapporto P/E:
-6.0253
EPS:
-3.0853
Flusso di cassa netto:
$-185.92M
1 W Prestazione:
+9.01%
1M Prestazione:
+11.62%
6M Prestazione:
+135.92%
1 anno Prestazione:
+98.35%
Intervallo 1D:
$17.30
$19.01
Intervallo di 1 settimana:
$17.30
$19.01
Portata 52W:
$5.1501
$19.01
Immunome Inc Stock (IMNM) Company Profile
Nome
Immunome Inc
Settore
Industria
Telefono
610-321-3700
Indirizzo
18702 N. CREEK PARKWAY, BOTHELL
Confronta IMNM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IMNM
Immunome Inc
|
18.59 | 1.61B | 12.59M | -212.39M | -185.92M | -3.0853 |
|
VRTX
Vertex Pharmaceuticals Inc
|
431.25 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.72 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.20 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
922.42 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
199.38 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Immunome Inc Stock (IMNM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-22 | Iniziato | Goldman | Buy |
| 2025-09-05 | Iniziato | Craig Hallum | Buy |
| 2025-04-02 | Iniziato | Lake Street | Buy |
| 2024-11-08 | Iniziato | Stephens | Overweight |
| 2024-05-31 | Iniziato | Piper Sandler | Overweight |
| 2024-04-30 | Iniziato | JP Morgan | Overweight |
| 2024-04-15 | Iniziato | Guggenheim | Buy |
| 2024-01-29 | Iniziato | Leerink Partners | Outperform |
| 2023-12-19 | Iniziato | Wedbush | Outperform |
| 2021-10-29 | Iniziato | Cantor Fitzgerald | Overweight |
Mostra tutto
Immunome Inc Borsa (IMNM) Ultime notizie
Immunome stock hits 52-week high at $18.79 By Investing.com - Investing.com Nigeria
Will Immunome Inc. stock attract more institutional investorsEarnings Overview Summary & Fast Momentum Stock Entry Tips - newser.com
What technical signals suggest for Immunome Inc. stockEarnings Overview Summary & AI Driven Stock Movement Reports - newser.com
How Immunome Inc. stock benefits from tech adoptionTrade Analysis Summary & Short-Term Trading Alerts - newser.com
Will Immunome Inc. stock outperform value stocks2025 Geopolitical Influence & Weekly Top Performers Watchlists - newser.com
Is Immunome Inc. stock a safe haven assetGDP Growth & Weekly Top Gainers Trade List - newser.com
Is Immunome Inc. stock bottoming out2025 Bull vs Bear & Risk Controlled Stock Pick Alerts - newser.com
Can swing trading help recover from Immunome Inc. lossesJuly 2025 Action & Daily Volume Surge Signals - newser.com
Discipline and Rules-Based Execution in IMNM Response - news.stocktradersdaily.com
Stephens raises Immunome stock price target to $33 on varegacestat potential - Investing.com Nigeria
IMNM Analyst Rating Update: Stephens & Co. Raises Price Target | - GuruFocus
Immunome price target raised to $33 from $25 at Stephens - TipRanks
Is Immunome’s (IMNM) Improved Efficiency a Sign of Lasting Strength in the Biotech Race? - simplywall.st
Can Immunome Inc. stock deliver surprise earnings beat2025 Buyback Activity & Expert Curated Trade Setup Alerts - newser.com
Historical volatility pattern of Immunome Inc. visualizedQuarterly Risk Review & Weekly Top Gainers Trade List - newser.com
What drives Immunome Inc stock priceSmall Cap Stock Opportunities & Free Daily Market Summary and Trend Reports - earlytimes.in
What Makes Escorts Kubota Limited a Resilient Investment During CrisesCash Flow Trends & Master Timing Market Moves - earlytimes.in
Immunome stock hits 52-week high at 17.89 USD By Investing.com - Investing.com Canada
How Immunome Inc. stock performs in rate cut cyclesMarket Weekly Review & AI Powered Market Entry Ideas - newser.com
Immunome stock hits 52-week high at 17.89 USD - Investing.com
Will Immunome Inc. stock reach Wall Street targetsQuarterly Investment Review & High Conviction Investment Ideas - newser.com
Immunome, Inc. Reports Q3 2025 Financial Results - TipRanks
Can Immunome's (IMNM) Reduced Losses Point to a Sustainable Shift in Operational Strategy? - simplywall.st
Immunome Inc Azioni (IMNM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Immunome Inc Azioni (IMNM) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| BIENAIME JEAN JACQUES | Director |
Jun 03 '25 |
Buy |
9.38 |
5,000 |
46,900 |
36,415 |
| Higgins Jack | Chief Scientific Officer |
Mar 27 '25 |
Option Exercise |
1.35 |
5,200 |
7,020 |
18,729 |
| BIENAIME JEAN JACQUES | Director |
Mar 25 '25 |
Buy |
7.78 |
7,800 |
60,684 |
31,415 |
| SIEGALL CLAY B | President and CEO |
Mar 26 '25 |
Buy |
7.29 |
137,100 |
999,459 |
806,736 |
| BIENAIME JEAN JACQUES | Director |
Mar 24 '25 |
Buy |
8.21 |
7,000 |
57,470 |
23,615 |
| Tsai Philip | Chief Technology Officer |
Mar 24 '25 |
Buy |
8.42 |
12,300 |
103,566 |
33,300 |
| SIEGALL CLAY B | President and CEO |
Jan 31 '25 |
Buy |
7.75 |
150,000 |
1,162,500 |
669,636 |
| SIEGALL CLAY B | President and CEO |
Nov 22 '24 |
Buy |
9.78 |
33,943 |
331,918 |
519,636 |
1.75%
0.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):